Nonprescription pharmaceuticals

Summary report concerning safety and efficacy of nonprescription pharmaceutical product. ... 

Estimated aqueous concentratiorrs of nonprescription pharmaceuticals (Table 10. 1) recovered from POCIS samplers at each samphng location ate presented in Table 10.4. Aqueous concentrations were calculated using Eq. (2) with experimentally determined uptake rates (Table 10.2). 

The current use of pharmaceuticals is staggering. More than 4 billion medical prescriptions were dispensed in the United States in 2013, with more than 45 percent of all residents having been prescribed at least one pharmaceutical compound every month. The use of nonprescription pharmaceuticals is equally impressive for example, the annual consumption of aspirin in the United States exceeds 10,000 tons. 

W. E. Gilbertson, in T. R. Covington, ed.. Handbook of Nonprescription Drugs, 10th ed., American Pharmaceutical Association, Washington, D.C.,... 

Billow JA. Acne. In Berardi RR, McDermott JH, Newton GD, et al, eds. The Handbook of Nonprescription Drugs. 14th ed. Washington, DC American Pharmaceutical Association, 2004 913-928. Cheigh NH. Atopic dermatitis. In DiPiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy A Pathophysiologic Approach. 6th ed. New York City McGraw-Hill, 2005 1785-1792. 

Keefner KR. Contact dermatitis. In Berardi RR, McDermott JH, Newton GD, et al, eds. Handbook of Nonprescription Drugs. 14th ed. Washington, DC American Pharmaceutical Association, 2004 849-871. 

Nonprescription Drugs. 14th ed. Washington, DC American Pharmaceutical Association, 2004 873-888. 

Figure 1 shows pharmaceutical expenditures, both prescription and nonprescription, per capita in industrialized countries in 1997. Comparing the numbers in this figure with those in Table 2, it is possible to estimate per capita pharmaceutical expenditures for... 

Fig. 1 Per capita pharmaceutical expenditures in industrialized countries. Pharmaceuticals include nonprescription products. 1996 data. (From OECD Health Data, 1998.)...

Nonsteroidal anti-inflammatory agents are used extensively as nonprescription drugs, and residues of these compounds have been detected ubiquitously in WWTP effluents at the pg L 1 levels, and they also frequently occur at the ng L 1 level in the aquatic environment (see [2], this volume). As a result, many researchers have focused on the degradation of these pharmaceuticals, which are one of the most studied groups of therapeutic agents in terms of fungal transformation. 

In 1997, the nonprescription market expressed in the percentage of the total pharmaceutical mcirket in Vedues Wcis 16.2 percent (AESGP 1998). 

Generally, there is no contract between the pharmaceutical company and the patient who is prescribed the product by a doctor. In the United Kingdom, it has been held that where a product is prescribed under a National Health Service scheme, it is not prescribed as a result of a contract between the pharmaceutical company and the patient because legislation exists that requires a pharmacist to supply the product on the production of a valid prescription. For nonprescription, over-the-counter (OTC) products, there is a contract between the retailer and the consumer who purchases the pharmaceutical product, but there is still usually no direct link in contractual terms to the manufacturer of the product. It may be, however, that the contract between the manufacturer and the retailer contains an indemnity provision. Then, in the event of a successful claim for breach of contract made against the retailer by the customer, the manufacturer would effectively be required to reimburse the retailer for the amount ordered to be paid in compensation to the customer. 

APhA reference books include the Handbook of Nonprescription Drugs, 13th Edition, Medication Errors, Handbook of Pharmaceutical Excipients, APhA Drug Treatment Protocols, and several texts to guide those engaged in compounding practice. 

The Canadian Pharmaceutical Association (CPhA) was founded in September 1907 as a national body for the profession of pharmacy in Canada. Its involvement in publishing began early in its history with the assumption of responsibility for the Canadian Formulary in 1929. The first edition of the Compendium of Pharmaceuticals and Specialties (CPS) was publi.shed in 1960 and continues today, along with a number of other well-respected health care publications including Nonprescription Drug Reference for Health Professionals, Compendium of Nonprescription Products, Therapeutic Choices, and Herbs Everyday Reference for Health Professionals. The latter is published jointly with the Canadian Medical Association. 

There are severe acute and chronic concerns around pediatric medicines containing ethanol. Hepatic metabolism of ethanol involves a nonlinear saturable pathway. Young children have a limited ability to metabolize and thereby detoxify ethanol. Ethanol intoxication has been recorded in children with blood levels as low as 25 mg/dL. Alcohol has a volume of distribution of approximately 0.65 L/kg. Ingestion of 20 mL of a 10% alcohol solution will produce a blood level of 25 mg/dL in a 30-lb. child. The American Academy of Pediatrics (AAP) Committee on Drugs recommends that pharmaceutical formulations intended for use in children should not produce ethanol blood levels of >25 mg/dL after a single dose. In general, manufacturers have voluntarily complied with the recommendations. In 1992 the Nonprescription Drug Manufacturers Association established voluntary limits for alcohol content of nonprescription products (65). 

From a pharmaceutical standpoint there are many different criteria which can be used to classify medications type of formulation, the frequency with which it is prescribed or recommended, price, refundibihty, prescription or nonprescription... 

---